Lumos Diagnostics (ASX:LDX) has reported encouraging real-world data from the use of its FebriDx point-of-care test across general practice, urgent care, and Acute Respiratory Infection (ARI) hubs in the UK, showing the device can reduce unnecessary antibiotic use, improve patient satisfaction, and ease health system costs.
The data, presented at the Primary Care Respiratory Society (PCRS) Annual Conference in Telford, drew on nearly two years of experience in Calderdale, West Yorkshire, where the test was integrated into routine respiratory care.
FebriDx distinguishes between bacterial and viral respiratory infections in just 10 minutes from a simple finger-prick blood test, combining C-Reactive Protein (CRP) and the viral biomarker MxA.
Clinicians reported increased confidence in their prescribing decisions, resulting in measurable reductions in antibiotic use. Patients experienced fewer repeat consultations and said the test provided reassurance about their diagnosis. A retrospective survey of more than 1,100 patients found that 85 per cent of those tested found it helpful, while over a third said they would otherwise have gone to accident and emergency if the ARI hub appointment had not been available.
The program also generated significant cost savings by avoiding unnecessary prescriptions, reducing reconsultations, and preventing hospital admissions. The PCRS patient reference group recognised the Calderdale study with the award for Most Patient-Centred Poster.
Paul Kase, Lumos Diagnostics’ Senior Vice President of Commercial Operations, said the results validated what had been observed in practice. “When given rapid, reliable viral versus bacterial confirmation, clinicians are more confident in their decisions. This drives patient benefit and health system savings. We’re grateful to Muzammel Fazlee, the Calderdale team and all those involved in reporting these important findings.”
Beyond antimicrobial stewardship, patients also valued the speed and ease of the test. While some found the finger-prick uncomfortable or confusing without a clear explanation, most described it as quick, simple, and reassuring.
Lumos said the test aligns with UK National Health Service goals to shift more care into the community and move from a model of 'sickness to prevention', offering practical support to over-burdened health systems